BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2069128)

  • 1. The expression of CD22 (Leu 14) and CD11c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis.
    Miller ML; Fishleder AJ; Tubbs RR
    Am J Clin Pathol; 1991 Jul; 96(1):100-8. PubMed ID: 2069128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia.
    Robbins BA; Ellison DJ; Spinosa JC; Carey CA; Lukes RJ; Poppema S; Saven A; Piro LD
    Blood; 1993 Aug; 82(4):1277-87. PubMed ID: 7688993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry.
    Segal GH; Edinger MG; Owen M; McNealis M; Lopez P; Perkins A; Linden MD; Fishleder AJ; Stoler MH; Tubbs RR
    Cytometry; 1991; 12(4):350-9. PubMed ID: 1712263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases.
    Batata A; Shen B
    Cancer; 1992 Nov; 70(10):2436-43. PubMed ID: 1384948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Carotenuto M
    Am J Hematol; 2000 Aug; 64(4):275-81. PubMed ID: 10911380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human basophils express CD22 without expression of CD19.
    Han K; Kim Y; Lee J; Lim J; Lee KY; Kang CS; Kim WI; Kim BK; Shim SI; Kim SM
    Cytometry; 1999 Nov; 37(3):178-83. PubMed ID: 10520197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion molecules in B-chronic lymphoproliferative disorders.
    Angelopoulou MK; Kontopidou FN; Pangalis GA
    Semin Hematol; 1999 Apr; 36(2):178-97. PubMed ID: 10319387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A; Wang CY; McKenzie S; Clarkson BD; Koziner B
    Am J Hematol; 1992 Aug; 40(4):264-9. PubMed ID: 1354412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry.
    Huang J; Fan G; Zhong Y; Gatter K; Braziel R; Gross G; Bakke A
    Am J Clin Pathol; 2005 Jun; 123(6):826-32. PubMed ID: 15899772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
    Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
    Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.
    Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL
    J Immunol; 1988 Jun; 140(12):4271-8. PubMed ID: 2453575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal lymphocytosis with villous lymphocytes: a chronic lymphoproliferative disease of CD11c+ B-cells.
    Bassan R; Neonato MG; Abbate M; Motta T; Barbui T; Rambaldi A
    Leukemia; 1991 Sep; 5(9):799-806. PubMed ID: 1682536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.
    Lúcio PJ; Faria MT; Pinto AM; da Silva MR; Correia Júnior ME; da Costa RJ; Parreira AB
    Haematologica; 1998 Feb; 83(2):104-11. PubMed ID: 9549920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hairy cell leukemia variant: fact or fiction.
    Cessna MH; Hartung L; Tripp S; Perkins SL; Bahler DW
    Am J Clin Pathol; 2005 Jan; 123(1):132-8. PubMed ID: 15762289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides.
    Rani S; De Oliveira MS; Catovsky D
    Hematol Pathol; 1988; 2(2):73-8. PubMed ID: 2974027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.
    Koníková E; Kusenda J; Babusíková O; Glasová M
    Neoplasma; 1995; 42(5):227-34. PubMed ID: 8552200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.